iBio (IBIO) announced the appointment of biotech industry veterans David Arkowitz and Antonio Parada to its Board of Directors adding key experience in finance, leadership and antibody discovery. Arkowitz is currently Chief Financial Officer at Alkeus Pharmaceuticals, a private company developing therapies for serious diseases of the eye with high unmet need. Parada is the Founder and CEO of FairJourney Biologics, a privately held and leading antibody discovery contract research organization
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter